Trends in Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma: Lessons for Resource-Challenged Regions
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Trends in Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma: Lessons for Resource-Challenged Regions ; day:03 ; month:12 ; year:2022
Indian journal of medical & paediatric oncology ; (03.12.2022)
- Beteiligte Personen und Organisationen
-
Lad, Deepesh P.
- DOI
-
10.1055/s-0042-1754373
- URN
-
urn:nbn:de:101:1-2023011913224081229147
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:23 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lad, Deepesh P.
Ähnliche Objekte (12)
Maintenance Strategies Post-Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma
Single versus tandem autologous stem cell transplantation in newly diagnosed multiple myeloma
Treatment benefit of upfront autologous stem cell transplantation for newly diagnosed multiple myeloma: a systematic review and meta-analysis
Current status of autologous stem cell transplantation for multiple myeloma
Newly diagnosed multiple myeloma patients with CD56 expression benefit more from autologous stem cell transplantation
Mobilization Strategies in Myeloma Patients Intended for Autologous Hematopoietic Cell Transplantation
Case for More Autologous Transplants in Myeloma in Resource-Constrained Settings
Real-world results of autologous stem cell transplantation in newly diagnosed multiple myeloma: a report from the Canadian Myeloma Research Group database
Autologous bone marrow transplantation for Hodgkin's disease, non-Hodgkin's lymphoma and multiple myeloma
Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma
Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma
Lenalidomide vs bortezomib maintenance choice post-autologous hematopoietic cell transplantation for multiple myeloma
Maintenance Strategies Post-Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma
Single versus tandem autologous stem cell transplantation in newly diagnosed multiple myeloma
Treatment benefit of upfront autologous stem cell transplantation for newly diagnosed multiple myeloma: a systematic review and meta-analysis
Current status of autologous stem cell transplantation for multiple myeloma
Newly diagnosed multiple myeloma patients with CD56 expression benefit more from autologous stem cell transplantation
Mobilization Strategies in Myeloma Patients Intended for Autologous Hematopoietic Cell Transplantation
Case for More Autologous Transplants in Myeloma in Resource-Constrained Settings
Real-world results of autologous stem cell transplantation in newly diagnosed multiple myeloma: a report from the Canadian Myeloma Research Group database
Autologous bone marrow transplantation for Hodgkin's disease, non-Hodgkin's lymphoma and multiple myeloma
Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma
Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma
Lenalidomide vs bortezomib maintenance choice post-autologous hematopoietic cell transplantation for multiple myeloma
Maintenance Strategies Post-Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma
Single versus tandem autologous stem cell transplantation in newly diagnosed multiple myeloma
Treatment benefit of upfront autologous stem cell transplantation for newly diagnosed multiple myeloma: a systematic review and meta-analysis
Current status of autologous stem cell transplantation for multiple myeloma
Newly diagnosed multiple myeloma patients with CD56 expression benefit more from autologous stem cell transplantation
Mobilization Strategies in Myeloma Patients Intended for Autologous Hematopoietic Cell Transplantation
Case for More Autologous Transplants in Myeloma in Resource-Constrained Settings
Real-world results of autologous stem cell transplantation in newly diagnosed multiple myeloma: a report from the Canadian Myeloma Research Group database
Autologous bone marrow transplantation for Hodgkin's disease, non-Hodgkin's lymphoma and multiple myeloma
Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma
Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma